TLSA Stock Summary and Trading Ideas (Tiziana Life Sciences - Common Shares | NASDAQ:TLSA)

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Tiziana Life Sciences - Common Shares trades on the NASDAQ stock market under the symbol TLSA.

As of January 22, 2026, TLSA stock price declined to $1.66 with 256,015 million shares trading.

TLSA has a beta of -0.91, meaning it tends to be less sensitive to market movements. TLSA has a correlation of 0.02 to the broad based SPY ETF.

TLSA has a market cap of $211.23 million. This is considered a Small Cap stock.

In the last 3 years, TLSA traded as high as $2.60 and as low as $.41.

TLSA has outperformed the market in the last year with a price return of +126.0% while the SPY ETF gained +15.5%. However, in the short term, TLSA had mixed performance relative to the market. It has underperformed in the last 3 months, returning -12.2% vs +2.9% return in SPY. But in the last 2 weeks, TLSA shares have fared better than the market returning +10.7% compared to SPY -0.1%.

TLSA support price is $1.60 and resistance is $1.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TLSA shares will trade within this expected range on the day.